Search Results 831-840 of 17158 for treatment resistant depression
Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and help relieve symptoms of arthritis (osteoarthritis and ...
Post Approval Study for Treatment of Drug-resistant Adult Primary FSGS Using the LIPOSORBER® LA-15 System. Rochester, Minn., Jacksonville, Fla. The purpose ...
Depression and anxiety after a heart attack are ... Participants who were treated ... Mayo Clinic's SCAD Research Program also is studying possible treatments for ...
Diagnosis of major depression disorder, acute anxiety disorder or schizophrenia per medical record; Participating in other psychosocial intervention research ...
Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments that treat this condition. Psychiatry and ...
By condition, treatment or drug name. Search tips. Study to Evaluate Mechanisms of Immunomodulator Sensitivity and Resistance in Multiple Myeloma. Print ...
... resistant chronic lymphocytic leukemia. Patients ... Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since ...
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study to ...
Areas of focus: Cognitive behavioral therapy, Psychotherapy, Acceptance and commitment therapy, Insomnia, Depression, Anxiety disorder,... Generalized ...
The purpose of this study is to test GC012F, a CD19/BCMA dual CART-cell therapy, in adult subjects with relapsed/refractory Multiple Myeloma. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.